Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathway

BMC Complementary and Alternative Medicine

Volumn 10, Issue , 2010, Pages

  Liu, Chang ^b,c   Li, Jianqin ^b   Meng, Fan Y ^a   Liang, Simon X ^e   Deng, Ruixia ^c   Li, Chi K ^f   Pong, NH ^f   Lau, Ching P ^f   Cheng, Sau W ^f   Ye, Jie Y ^c   Chen, Jian L ^c   Yang, ST ^c   Yan, Haixia ^b   Chen, Shilin ^b   Chong, Beng H ^e   Yang, Mo ^a,c,d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d SUN YAT SEN UNIVERSITY   (China)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGELICA SINENSIS EXTRACT; CASPASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; POLYSACCHARIDE; PROTEIN KINASE B; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; HERBACEOUS AGENT; MORPHOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD CELL; BONE MARROW SUPPRESSION; CELL LINEAGE; CHINESE MEDICINE; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MALE; MEGAKARYOCYTE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; THROMBOCYTOPOIESIS; ANGELICA SINENSIS; ANIMAL; CELL PROLIFERATION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; METABOLISM; PLANT ROOT; SIGNAL TRANSDUCTION; STEM CELL;

ANGELICA SINENSIS; ANIMALS; APOPTOSIS; BLOOD CELLS; CELL PROLIFERATION; CHROMONES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HEMATOPOIESIS; MEGAKARYOCYTES; MICE; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASE; PLANT ROOTS; POLYSACCHARIDES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STEM CELLS; THROMBOPOIESIS;

EID: 78650269544     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-10-79     Document Type: Article

References (45)

1. Ciurea SO, Hoffman R. Cytokines for the treatment of thrombocytopenia. Semin Hematol 2007, 44:166-182. 10.1053/j.seminhematol.2007.04.005, 17631181.
2. Mei QB, Tao JY, Cui B. Advances in the pharmacological studies of radix Angelica sinensis (Oliv) Diels (Chinese Danggui). Chin Med J (Engl) 1991, 104:776-781.
3. Wang Y, Zhu B. The effect of angelica polysaccharide on proliferation and differentiation of hematopoietic progenitor cell. Zhonghua Yi Xue Za Zhi 1996, 76:363-366.
4. Yang M, Chan GC, Deng R, Ng MH, Cheng SW, Lau CP, Ye JY, Wang L, Liu C. An herbal decoction of Radix astragali and Radix angelicae sinensis promotes hematopoiesis and thrombopoiesis. J Ethnopharmacol 2009, 124:87-97. 10.1016/j.jep.2009.04.007, 19443149.
5. WANG KP, CHEN ZX, ZHANG Y, WANG PP, WANG JH, DAI LQ. Molecular Weight and Proposed Structure of the Angelica sinensis Polysaccharide-iron Complex. Chinese Journal of Chemistry 2008, 26:1068-1074.
6. Cho CH, Mei QB, Shang P, Lee SS, So HL, Guo X, Li Y. Study of the gastrointestinal protective effects of polysaccharides from Angelica sinensis in rats. Planta Med 2000, 66:348-351. 10.1055/s-2000-8552, 10865452.
7. Ye YN, Koo MW, Li Y, Matsui H, Cho CH. Angelica sinensis modulates migration and proliferation of gastric epithelial cells. Life Sci 2001, 68:961-968. 10.1016/S0024-3205(00)00994-2, 11213366.
8. Ye YN, Liu ES, Shin VY, Koo MW, Li Y, Wei EQ, Matsui H, Cho CH. A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line. Biochem Pharmacol 2001, 61:1439-1448. 10.1016/S0006-2952(01)00625-6, 11331080.
9. Ye YN, So HL, Liu ES, Shin VY, Cho CH. Effect of polysaccharides from Angelica sinensis on gastric ulcer healing. Life Sci 2003, 72:925-932. 10.1016/S0024-3205(02)02332-9, 12493573.
10. Shang P, Qian AR, Yang TH, Jia M, Mei QB, Cho CH, Zhao WM, Chen ZN. Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis. World J Gastroenterol 2003, 9:1963-1967.
11. Tsai NM, Lin SZ, Lee CC, Chen SP, Su HC, Chang WL, Harn HJ. The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo. Clin Cancer Res 2005, 11:3475-3484. 10.1158/1078-0432.CCR-04-1827, 15867250.
12. Inagaki K, Oda T, Naka Y, Shinkai H, Komatsu N, Iwamura H. Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities. Blood 2004, 104:58-64. 10.1182/blood-2003-10-3623, 15001470.
13. Sun L, Liu X, Qiu L, Wang J, Liu M, Fu D, Luo Q. Administration of plasmid DNA expressing human interleukin-6 significantly improves thrombocytopoiesis in irradiated mice. Ann Hematol 2001, 80:567-572. 10.1007/s002770100345, 11732866.
14. Yang M, Li K, Ng PC, Chuen CK, Lau TK, Cheng YS, Liu YS, Li CK, Yuen PM, James AE, et al. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis. Stem Cells 2007, 25:1800-1806. 10.1634/stemcells.2007-0048, 17446559.
15. Yang M, Li K, Chui CM, Yuen PM, Chan PK, Chuen CK, Li CK, Fok TF. Expression of interleukin (IL) 1 type I and type II receptors in megakaryocytic cells and enhancing effects of IL-1beta on megakaryocytopoiesis and NF-E2 expression. Br J Haematol 2000, 111:371-380. 10.1046/j.1365-2141.2000.02340.x, 11091227.
16. Yang M, Li K, Lam AC, Yuen PM, Fok TF, Chesterman CN, Chong BH. Platelet-derived growth factor enhances granulopoiesis via bone marrow stromal cells. Int J Hematol 2001, 73:327-334. 10.1007/BF02981957, 11345198.
17. Sungaran R, Chisholm OT, Markovic B, Khachigian LM, Tanaka Y, Chong BH. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells. Blood 2000, 95:3094-3101.
18. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433. 10.1126/science.1698311, 1698311.
19. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M. MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4?. J Exp Med 1999, 189:1777-1782. 10.1084/jem.189.11.1777, 2193086, 10359581.
20. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science 1998, 282:2085-2088. 10.1126/science.282.5396.2085, 9851930.
21. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D. Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4?Tlr4). J Exp Med 1999, 189:615-625. 10.1084/jem.189.4.615, 2192941, 9989976.
22. Jiang Q, Akashi S, Miyake K, Petty HR. Cutting Edge: Lipopolysaccharide Induces Physical Proximity Between CD14 and Toll-Like Receptor 4 (TLR4) Prior to Nuclear Translocation of NF-{kappa}B. J Immunol 2000, 165:3541-3544.
23. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex. TRANSFER FROM CD14 TO TLR4 AND MD-2. J Biol Chem 2001, 276:21129-21135. 10.1074/jbc.M009164200, 11274165.
24. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH. Reciprocal Modulation of Toll-like Receptor-4 Signaling Pathways Involving MyD88 and Phosphatidylinositol 3-Kinase/AKT by Saturated and Polyunsaturated Fatty Acids. J Biol Chem 2003, 278:37041-37051. 10.1074/jbc.M305213200, 12865424.
25. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003, 15:5-11. 10.1016/S0952-7915(02)00013-4, 12495726.
26. Medzhitov R, Janeway CA. Innate immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91:295-298. 10.1016/S0092-8674(00)80412-2, 9363937.
27. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000, 11:372-378.
28. Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000, 11:362-371.
29. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Takeda K, Akira S. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999, 231:59-65. 10.1016/S0378-1119(99)00098-0, 10231569.
30. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001, 1518:157-161.
31. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103. 10.1038/35074106, 11323673.
32. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745. 10.1038/35047123, 11130078.
33. Medzhitov R, Janeway C. The Toll receptor family and microbial recognition. Trends Microbiol 2000, 8:452-456. 10.1016/S0966-842X(00)01845-X, 11044679.
34. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002, 3:196-200. 10.1038/ni758, 11812998.
35. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex. J Immunol 2000, 164:558-561.
36. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF. The Extra Domain A of Fibronectin Activates Toll-like Receptor 4. J Biol Chem 2001, 276:10229-10233. 10.1074/jbc.M100099200, 11150311.
37. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1:398-401. 10.1038/80833, 11062499.
38. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4. J Biol Chem 2001, 276:16683-16689. 10.1074/jbc.M011695200, 11278967.
39. Byrd-Leifer CA, Block EF, Takeda K, Akira S, Ding A. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur J Immunol 2001, 31:2448-2457. 10.1002/1521-4141(200108)31:8<2448::AID-IMMU2448>3.0.CO;2-N, 11500829.
40. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738. 10.1038/35099560, 11607032.
41. Ishii KJ, Takeshita F, Gursel I, Gursel M, Conover J, Nussenzweig A, Klinman DM. Potential Role of Phosphatidylinositol 3 Kinase, rather than DNA-dependent Protein Kinase, in CpG DNA-induced Immune Activation. J Exp Med 2002, 196:269-274. 10.1084/jem.20020773, 2193923, 12119352.
42. Manna SK, Aggarwal BB. Wortmannin inhibits activation of nuclear transcription factors NF-kappaB and activated protein-1 induced by lipopolysaccharide and phorbol ester. FEBS Lett 2000, 473:113-118. 10.1016/S0014-5793(00)01501-5, 10802070.
43. Fruman DA, Snapper SB, Yballe CM, Alt FW, Cantley LC. Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell development and proliferation. Biochem Soc Trans 1999, 27:624-629.
44. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000, 1:533-540. 10.1038/82797, 11101877.
45. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003, 17:590-603. 10.1038/sj.leu.2402824, 12646949.